Advisory Research’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Sell	19,595 -380	-2%	-$19.4K	0.12%	111
2025 Q4	$993K	Buy	19,975 +921	+5%	+$44.8K	0.12%	107
2025 Q3	$911K	Buy	19,054 +657	+4%	+$26.5K	0.12%	112
2025 Q2	$580K	Buy	18,397 +1,175	+7%	+$37.7K	0.09%	122
2025 Q1	$564K	Buy	17,222 +43	+0.3%	+$1.52K	0.1%	122
2024 Q4	$621K	Buy	17,179 +82	+0.5%	+$2.89K	0.1%	126
2024 Q3	$533K	Buy	17,097 +331	+2%	+$10.3K	0.09%	132
2024 Q2	$448K	Buy	16,766 +1,069	+7%	+$31K	0.08%	139
2024 Q1	$535K	Sell	15,697 -811	-5%	-$24.1K	0.11%	128
2023 Q4	$478K	Sell	16,508 -1,030	-6%	-$27.3K	0.07%	241
2023 Q3	$484K	Sell	17,538 -554	-3%	-$16.9K	0.07%	284
2023 Q2	$544K	Buy	18,092 +713	+4%	+$24.9K	0.07%	279
2023 Q1	$630K	Buy	17,379 +217	+1%	+$8.34K	0.1%	223
2022 Q4	$612K	Sell	17,162 -9,562	-36%	-$332K	0.06%	227
2022 Q3	$905K	Buy	26,724 +93	+0.3%	+$3.03K	0.09%	176
2022 Q2	$770K	Buy	26,631 +2,400	+10%	+$68.7K	0.08%	184
2022 Q1	$783K	Buy	+24,231	New	+$743K	0.06%	210